Skip to main content

Table 3 Central and peripheral blood pressure at each visit

From: Effect of Amlodipine/Nebivolol combination therapy on central BP and PWV compared to Amlodipine/Valsartan combination therapy

 

A/V [n = 52 (%)]

A/N [n = 50 (%)]

Systole

Diastole

Systole

Diastole

OBP

1st

158.3 ± 15.0

[154.1, 62.5]

99.9 ± 8.4

[97.5, 102.2]

154.7 ± 12.3

[151.2, 158.1]

97.7 ± 6.1

[95.9, 99.4]

2nd

133.9 ± 11.2

84.7 ± 7.3

134.6 ± 10.3

83.8 ± 7.8

3rd

126.1 ± 8.8

78.6 ± 6.8

123.1 ± 10.0

79.0 ± 7.8

CBP

1st

135.9 ± 14.7

[131.8, 40.0]

93.6 ± 11.4

[90.4, 96.8]

135.2 ± 11.3

[132.0, 138.4]

91.5 ± 9.5

[88.8, 94.3]

2nd

118.9 ± 7.6

83.9 ± 10.0

121.6 ± 9.5

84.9 ± 8.1

3rd

113.4 ± 8.5

78.8 ± 9.9

114.2 ± 12.3

79.5 ± 8.2

  1. A/V, Amlodipine/Valsartan; A/N, Amlodipine/Nebivolol; OBP, office blood pressure; CBP, central BP; 1st, first visit without medications (A/V or A/N); 2nd, second visit (on either A/V or A/N); 3rd, visit (on either A/V or A/N)